Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7410 p104
22 July 2006

This article
Reprint   Photocopy

PDF 70K, Acrobat Reader

Letters

· Professional regulation
· Code of Ethics (2)
· The profession (4)
· Community pharmacy (2)
· Multiples
· Accuracy checking
· CPPE (3)
· Medicines use review
· Emergency supplies (2)
· Controlled Drugs
· NHS
· Nutrition
· Fellowship
· The Council
· Retention fees
· Section 60 Order


Letters to the Editor

Medicines use review

More chance of funding from a message in a bottle

From Dr E. K. Rosenbloom, MRPharmS

I write on behalf of Hertfordshire and Bedfordshire local pharmaceutical committees, which would like to highlight the needs of those who care for and support vulnerable people.

Parents and carers who manage complex medicines regimens for vulnerable people (specifically those with cognitive disabilities) are unable to access the support that could be offered as part of a medicines use review (MUR) and support service.

The development of new services, including MURs has been welcomed by LPCs. However, they think there should now be a review of the current service specification and regulations which they believe limits the delivery of the MUR service.

The issues associated with obtaining consent and providing medicines support for vulnerable people are complex, and need to be addressed with urgency. It is a great shame that the MUR advance services specification and the associated regulations seem to reinforce the inverse care law,1 thereby making people who most need support unable to access it.

In order to address this dilemma locally we are attempting to develop an enhanced service for vulnerable people. However, working with our peers in primary care organisations we find ourselves in yet another financial crisis caused by NHS underfunding and yet another period of NHS reorganisation and instability. In an ideal world our proposed enhanced service, which we are seeking to be commissioned, should be presented to practice-based commissioning boards.

In reality, the chances of getting funding would be greater if we were to write a message in a bottle and throw it into the English Channel. At least then the message might be found on the shores of a tropical island by a holidaying, socially responsible tycoon who could fund this service.

Karen Rosenbloom
Executive Officer
Bedfordshire LPC

Reference

1. Hart JT. The inverse care law. Lancet 1971;i:405–12.

Send your letter to The Editor

Previous Topic (CPPE)
Next Topic (Emergency supplies)

Back to Top


©The Pharmaceutical Journal